Benzinga | Oct 29, 2020 09:54AM EDT

Wells Fargo Maintains Overweight on ChemoCentryx, Lowers Price Target to $70

Wells Fargo maintains ChemoCentryx (NASDAQ:CCXI) with a Overweight and lowers the price target from $79 to $70.